4.91
前日終値:
$5.11
開ける:
$5.04
24時間の取引高:
10.46M
Relative Volume:
1.74
時価総額:
$871.39M
収益:
$2.54B
当期純損益:
$-207.36M
株価収益率:
-4.1261
EPS:
-1.19
ネットキャッシュフロー:
$151.25M
1週間 パフォーマンス:
-14.46%
1か月 パフォーマンス:
-30.35%
6か月 パフォーマンス:
-29.56%
1年 パフォーマンス:
-52.79%
Teladoc Health Inc Stock (TDOC) Company Profile
TDOC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
4.91 | 906.89M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
190.69 | 31.36B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.55 | 9.96B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
81.34 | 7.02B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.28 | 7.04B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
DOCS
Doximity Inc
|
35.25 | 6.56B | 550.17M | 201.35M | 232.07M | 1.00 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Equal Weight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-07-25 | 開始されました | Mizuho | Neutral |
| 2024-11-15 | 開始されました | Goldman | Buy |
| 2024-09-17 | 繰り返されました | Jefferies | Hold |
| 2024-02-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-17 | ダウングレード | DA Davidson | Buy → Neutral |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-04-12 | 開始されました | Stephens | Equal-Weight |
| 2023-02-23 | アップグレード | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | アップグレード | Guggenheim | Sell → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-17 | ダウングレード | Guggenheim | Neutral → Sell |
| 2022-08-12 | 開始されました | DA Davidson | Buy |
| 2022-08-02 | ダウングレード | Berenberg | Buy → Hold |
| 2022-08-02 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-07-28 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-28 | ダウングレード | Needham | Buy → Hold |
| 2022-07-06 | 繰り返されました | BofA Securities | Neutral |
| 2022-05-05 | ダウングレード | Argus | Buy → Hold |
| 2022-04-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-04-28 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-04-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-04-28 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-03 | アップグレード | Argus | Hold → Buy |
| 2022-02-23 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-23 | 繰り返されました | Craig Hallum | Hold |
| 2022-02-23 | 繰り返されました | Evercore ISI | In-line |
| 2022-02-23 | 繰り返されました | Goldman | Buy |
| 2022-02-23 | 繰り返されました | JP Morgan | Overweight |
| 2022-02-23 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | 繰り返されました | Needham | Buy |
| 2022-02-23 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-23 | 繰り返されました | Stifel | Hold |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2022-02-08 | 繰り返されました | Piper Sandler | Overweight |
| 2021-12-02 | 再開されました | Jefferies | Hold |
| 2021-11-22 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-10-28 | 繰り返されました | Barclays | Equal Weight |
| 2021-10-28 | 繰り返されました | BofA Securities | Neutral |
| 2021-10-28 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-10-28 | 繰り返されました | Citigroup | Buy |
| 2021-10-28 | 繰り返されました | Craig Hallum | Hold |
| 2021-10-28 | 繰り返されました | Needham | Buy |
| 2021-10-28 | 繰り返されました | Oppenheimer | Outperform |
| 2021-10-28 | 繰り返されました | Piper Sandler | Overweight |
| 2021-10-28 | 繰り返されました | UBS | Neutral |
| 2021-10-19 | 開始されました | Wells Fargo | Overweight |
| 2021-08-02 | ダウングレード | Argus | Buy → Hold |
| 2021-07-28 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-05-28 | 開始されました | Robert W. Baird | Neutral |
| 2021-04-15 | 開始されました | Needham | Buy |
| 2021-01-07 | 開始されました | BTIG Research | Buy |
| 2020-12-22 | 開始されました | Evercore ISI | In-line |
| 2020-12-07 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | 開始されました | Goldman | Neutral |
| 2020-11-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | 開始されました | DA Davidson | Buy |
| 2020-09-02 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-17 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | 開始されました | Citigroup | Buy |
| 2020-07-13 | 開始されました | Argus | Buy |
| 2020-07-07 | 開始されました | Stephens | Overweight |
| 2020-04-30 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | 開始されました | SVB Leerink | Outperform |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-25 | ダウングレード | Craig Hallum | Buy → Hold |
| 2020-03-16 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | 開始されました | UBS | Neutral |
| 2020-01-09 | ダウングレード | BofA/Merrill | Buy → Neutral |
すべてを表示
Teladoc Health Inc (TDOC) 最新ニュース
Jim Cramer on Teladoc: "I Don't See Any Reason to Own It" - Finviz
Jim Cramer on Teladoc: “I Don’t See Any Reason to Own It” - Insider Monkey
Lacklustre Performance Is Driving Teladoc Health, Inc.'s (NYSE:TDOC) 28% Price Drop - 富途牛牛
Teladoc Health, Inc.'s (NYSE:TDOC) 28% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st
Teladoc Health, Inc. (TDOC) Investor Outlook: Is The 66% Upside Within Reach? - DirectorsTalk Interviews
The Truth About Teladoc Health Inc: Is TDOC’s Telehealth Empire Still Worth Your Money? - AD HOC NEWS
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance Singapore
Teladoc Health (NYSE:TDOC) Hits New 12-Month LowHere's Why - MarketBeat
(TDOC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
A Look At Teladoc Health’s Valuation As Medicare Telehealth Policy And Options Activity Drive Uncertainty - Sahm
What are Teladoc Health Inc.’s earnings expectationsJuly 2025 Volume & Low Drawdown Investment Strategies - mfd.ru
Chuck Divita on why 2026 is Teladoc’s ‘execution year’ - Healthcare Dive
Teladoc hits all-time low as a risky pattern points to a deeper dive - TradingView
Published on: 2026-01-29 14:18:31 - baoquankhu1.vn
Teleoncology Market to Reach US$ 15.03 Billion by 2032 at 15.7% - openPR.com
A Look At Teladoc Health (TDOC) Valuation As Medicare And BetterHelp Concerns Drive Volatility - Yahoo Finance
Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? - The Globe and Mail
Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? - The Motley Fool
Medicare Telehealth Uncertainty And BetterHelp Weakness Test Teladoc Valuation - Sahm
Is Teladoc Health (TDOC) A Potential Opportunity After Prolonged Share Price Weakness - Yahoo Finance
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Why Teladoc (TDOC) Shares Are Plunging Today - Finviz
Teladoc Health (NYSE:TDOC) Hits New 1-Year LowShould You Sell? - MarketBeat
Are Telehealth Stocks Set to Tumble in 2026? - The Globe and Mail
Teladoc stock hits 52-week low at 6.03 USD - Investing.com
Teladoc price target lowered to $7 from $7.50 at BofA Securities - Investing.com Canada
Teladoc (TDOC) Sees Surge in Call Option Activity - GuruFocus
Teladoc offers free non-emergency care for Texans impacted by winter storm - CW33.com
Analyst Calls: What is the target price for Teladoc Health Inc stockQuarterly Market Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Teladoc’s Data-Driven 24/7 Care Upgrade Could Be A Game Changer For Teladoc Health (TDOC) - Sahm
Assessing Teladoc Health (TDOC) Valuation As Investor Caution Grows Despite Product Updates - Sahm
Is Teladoc’s Expanded 24/7 Care Data Strategy a Durable Edge in Virtual Care Competition (TDOC)? - Yahoo Finance
2 Beaten-Down Stocks That Could Sink Even More in 2026 - Finviz
Is Teladoc (TDOC) Now Offering Value After Multi‑Year Share Price Declines - Sahm
Sarepta and Teladoc Face Major Challenges, Stock Outlook Dim - Intellectia AI
Sarepta Therapeutics and Teladoc Health Face Major Challenges, 2026 Outlook Dismal - Intellectia AI
Teladoc Health Sees Unusually Large Options Volume (NYSE:TDOC) - MarketBeat
Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade) (NYSE:TDOC) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Teladoc (TDOC) and Immunome (IMNM) - The Globe and Mail
Teladoc Health shares tumble for seven consecutive sessions - MSN
Teladoc Health (TDOC) Faces Decline Amid Analyst Optimism - GuruFocus
Teladoc Health (TDOC) Shares Drop for Seven Consecutive Sessions, Losing Nearly 16% - Intellectia AI
Teladoc and EverQuote Shares Plummet, What You Need To Know - Finviz
(TDOC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
3 Reasons to Avoid TDOC and 1 Stock to Buy Instead - Finviz
Hims & Hers Expands Platform-Led Access to Digital Healthcare - The Globe and Mail
Analyst Downgrade: Can Teladoc Health Inc beat the S P 500Entry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
Teladoc stock hits 52-week low at $6.34 By Investing.com - Investing.com Nigeria
Aug Movers: What is Teladoc Health Incs TAM Total Addressable MarketWeekly Profit Recap & Real-Time Market Trend Scan - baoquankhu1.vn
Teladoc Health (NYSE:TDOC) Reaches New 52-Week LowTime to Sell? - MarketBeat
Teladoc stock hits 52-week low at $6.34 - Investing.com
Teladoc Health Inc (TDOC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):